Peer-reviewedLicence not statedBMJ Open6 Nov 2026

Integration of Immune checkpoint inhibitors within the definitive radiotherapy-based treatment continuum for locally advanced mucosal head and neck squamous cell carcinoma: a scoping review protocol

Ahmad Ameri¹
Shahrzad Ebrahimi²
Mansour Bahardoust³
Amirhosein Rayegani⁴
Shayan Sheikhmiri²
Mansour Lesan¹
Tannaz Malakouti²

4 affiliations

¹Department of Radiation Oncology, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
²Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
³Breast Cancer Research Centre, Iran University of Medical Sciences, Tehran, Iran
⁴Department of Radiation Oncology, Urmia University of Medical Sciences, Urmia, Iran

Open at source DOI Cite

Overall treatment time and oncologic outcomes after definitive radiotherapy or chemoradiotherapy for cervical cancer: a systematic review and meta-analysis
Yingding Ruan, Yun Li, Dan Wu +2
Frontiers in Oncology26 Oct 2026Peer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefDOAJ
Efficacy and Safety of Sequential Radiotherapy and Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Single-Center PSM Retrospective Cohort Study.
Huaxi Fan, Rong Yu, Guishu Wu +6
Journal of hepatocellular carcinoma28 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
Radiotherapy and immune checkpoint inhibitors in small cell lung cancer: a Web of Science Core Collection-based bibliometric analysis.
Weihan Wang, Zhonghua Chen, Yang Wang +2
Translational cancer research29 Sep 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
Artificial Intelligence, Multi-Omics, and Multimodal Integration in Precision Radiotherapy for Head and Neck Cancer: From Biological Insights to Treatment Decisions
Miao Rao, Yingjian Wang, Minglun Li +1
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Efficacy and safety of stereotactic body radiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis.
Pengfei Ji, Zhihui Zhao, Xinpu Tang +7
Translational lung cancer research28 Sep 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC

Cite

BibTeX RIS

BibTeX

@article{ameri2026integration,
  title = {{Integration of Immune checkpoint inhibitors within the definitive radiotherapy-based treatment continuum for locally advanced mucosal head and neck squamous cell carcinoma: a scoping review protocol}},
  author = {Ahmad Ameri and Shahrzad Ebrahimi and Mansour Bahardoust and Amirhosein Rayegani and Shayan Sheikhmiri and Mansour Lesan and Tannaz Malakouti},
  journal = {BMJ Open},
  year = {2026},
  month = nov,
  doi = {10.1136/bmjopen-2026-128016},
  url = {https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-128016},
}

RIS

TY  - JOUR
TI  - Integration of Immune checkpoint inhibitors within the definitive radiotherapy-based treatment continuum for locally advanced mucosal head and neck squamous cell carcinoma: a scoping review protocol
AU  - Ahmad Ameri
AU  - Shahrzad Ebrahimi
AU  - Mansour Bahardoust
AU  - Amirhosein Rayegani
AU  - Shayan Sheikhmiri
AU  - Mansour Lesan
AU  - Tannaz Malakouti
PY  - 2026
DA  - 2026/11/06
JO  - BMJ Open
DO  - 10.1136/bmjopen-2026-128016
UR  - https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-128016
SN  - 2044-6055
SN  - 2044-6055
ER  -

Related

Cite